Patrangsit Healthcare Group (PHG) Fair Value & Analysis
Healthcare · TH · Market cap 3.0B THB
Fair value as of: Jul 16, 2026
From 24 valuation models · updated 25 days ago
Share price +1.0% over the past month.
A solid business, screening 98% undervalued on our models.
What matters now
- The price is below even our cautious bear case (13.09 THB). The market is more pessimistic than our downside scenario.
- Solid quality (63/100) at a price below fair value, the discount is the argument here, not the business quality.
- A fairly wide model range (13.09 THB to 25.79 THB) leaves room in how you read the outcome.
Price vs Fair Value (3 years)
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Jul 16, 2026.
How to read this chart
37‑month range 9.96 THB – 15.62 THB · fair‑value band 13.09 THB – 25.79 THB · the 10.40 THB price screens below the 20.63 THB fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Jul 16, 2026.
Analysis
Patrangsit Healthcare Group (PHG) currently trades at 10.40 THB, while our model-based Fair Value estimate is 20.63 THB, implying the stock looks roughly 98.4% undervalued today. The Quality Score stands at 63/100 (solid quality), in the Healthcare sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high), always confirm before acting.
Over the trailing twelve months, Patrangsit Healthcare Group generated revenue of 2.5B THB at a net margin of 11.1%. Revenue declined 3.1% year over year. It earns a return on equity of 12.6%. Net debt stands at 134M THB. Fundamentals as of Jul 16, 2026
Our scenario range runs from 13.09 THB (bear case) to 25.79 THB (bull case); at 10.40 THB, the current price sits below that range. Bear and bull are the same models run on conservative and optimistic assumptions (margins, growth, valuation multiples), so a plausible valuation range, not a price target. The share trades about 26% below its 52-week high and 6% above its 52-week low, currently below its 200-day average. For context, the median of 10 Healthcare peers we cover trades at 11% fair-value upside, at 98%, PHG screens cheaper than that median.
Fair Value models
Each model estimates fair value its own way; the Fair Value above is the evidence-weighted blend. Evidence (0–100) measures how completely this model’s inputs are available: well-fed models carry more weight in the blend. The spread across models is intentional, each one stresses a different value driver; dividend models, for instance, come out structurally low when payout is small.
All 24 models by family
Widest divergence: Growth Earnings (20.26 THB) versus Asset-Based (4.94 THB). Highest evidence: Growth DCF (80).
Notify me when PHG reaches fair value
Free. You confirm by email (double opt-in) and can unsubscribe anytime in one click.
Key figures & financial health
More key figures
Figures from reported company fundamentals · as of Jul 16, 2026. TTM = trailing twelve months.
Quality Score breakdown
Of which business quality 66 · Market factors (momentum, volatility) 40
Non-valuation factor families (profitability, growth, cashflow, financial strength, momentum …), each academically grounded. Valuation itself sits in the Fair Value and is deliberately excluded here to avoid double-counting.
About the company
Patrangsit Healthcare Group Public Company Limited operates hospitals in Thailand. The company offers physical therapy, pediatric, eye, psychiatry, child and adolescent psychiatry, dental, pediatric dental, pediatric skin, pediatric gastrointestinal tract and liver, pediatric nervous system, orthopedic surgery, chest and heart surgery, general surgery, …
Full company description
Patrangsit Healthcare Group Public Company Limited operates hospitals in Thailand. The company offers physical therapy, pediatric, eye, psychiatry, child and adolescent psychiatry, dental, pediatric dental, pediatric skin, pediatric gastrointestinal tract and liver, pediatric nervous system, orthopedic surgery, chest and heart surgery, general surgery, urology surgery, neurosurgery, obstetrics and gynecology, ear, nose, throat, internal medicine, gastrointestinal and liver medicine, neuro medicine, pulmonary and respiratory, cardiology, hematology, pediatric pulmonary and respiratory, skin clinic, and pediatrics allergy services. It also provides pediatrics heart and kidney, hemodialysis, health check-up, radiology and laboratory, men's health services, gastrointestinal tract endoscopy, chemotherapy, and women oncology services. Patrangsit Healthcare Group Public Company Limited was incorporated in 1984 and is based in Pathum Thani, Thailand.
Company description, as reported by the company or data provider.
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
Patrangsit Healthcare Group reported revenue of 2.5B THB in FY2025 versus 2.0B THB in FY2021, a compound +6.2%/yr. Reported net income was 309M THB in FY2025, compounding −0.6%/yr from FY2021.
Watch PHG: get an alert when its fair value changes →
Peer Group
Medical Care Facilities · 261 stocks
How this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.
Valuation Multiples vs Medical Care Facilities median · lower = cheaper
Snowflake
Five quick dimensions, each 0 to 100: VALUE (fair-value potential), FUTURE (revenue growth), PAST (return on equity), HEALTH (low debt), DIVIDEND (yield). Green = this stock, grey = typical sector peer.
Insider activity: 40/100
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
ESG scores are not available for this stock yet. Values and ESG data are contextual and can differ between providers.
Similar stocks
10 more Medical Care Facilities stocks, each showing price versus our Fair Value estimate (as of Jul 16, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| HCA Healthcare, Inc HCA | $378.85 | $554.93 | +46% |
| Fresenius SE FRE | €41.73 | €32.15 | -23% |
| Dr. Sulaiman Al Habib Medical Services Group 4013 | 235.00 SAR | 112.37 SAR | -52% |
| IHH Healthcare Berhad, an investment holding company, Q0F | 2.58 SGD | 1.44 SGD | -44% |
| Tenet Healthcare Corporation THC | $194.91 | $338.05 | +73% |
| Rede D'Or São Luiz S.A RDOR3 | R$36.01 | R$47.31 | +31% |
| DaVita Inc DVA | $231.61 | $255.97 | +11% |
| Apollo Hospitals Enterprise Limited APOLLOHOSP | ₹8,955 | ₹2,955 | -67% |
| Fresenius Medical Care AG FMS | $24.68 | $45.60 | +85% |
| Aier Eye Hospital Group 300015 | ¥8.68 | ¥7.67 | -12% |
Compare Patrangsit Healthcare Group with another stock
Price, fair value, quality and upside side by side.
Explore undervalued stocks
More undervalued Healthcare stocks →
Frequently asked questions
Is Patrangsit Healthcare Group (PHG) overvalued or undervalued?
What is the fair value of PHG?
What is the quality score of PHG?
What is the revenue of Patrangsit Healthcare Group (PHG)?
What is the net profit margin of PHG?
Does Patrangsit Healthcare Group pay a dividend?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data, nothing guessed.
Track Patrangsit Healthcare Group and try Pro for 14 days
One email gets you 14 days of full Pro (review alerts, the 35,000+ stock screener, the diversification check) plus the monthly Top-25 report of the most undervalued quality stocks. No card, cancel anytime.
Zero risk: nothing is ever charged. After 14 days you decide whether to stay.